APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peptide Vaccine Industry Growth and Trends Forecast to 2032

29 December 2025112 pages

Choose your research edition.

Industry ResearchPeptide Vaccine Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Vaccine Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Peptide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Vaccine Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Vaccine Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Peptide Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peptide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peptide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Peptide Vaccine include Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies, Benovus Bio, Celgene Corporation, Immatics biotechnologies, ImmunoCellular Therapeutics and ISA Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peptide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peptide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Peptide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peptide Vaccine Market by Company

Anergis

Antigen Express

Apitope Technology

Artificial Cell Technologies

Benovus Bio

Celgene Corporation

Immatics biotechnologies

ImmunoCellular Therapeutics

ISA Pharmaceuticals

Lytix Biopharma

OncoTherapy Science

Peptech

Pharmasyntez

Spotlight Innovation

Sumitomo Dainippon Pharma

TapImmune

Targovax

Merck

Peptide Vaccine Segment by Type

Solution Phase Synthesis (SPS)

Solid Phase Peptide Synthesis (SPPS)

Peptide Vaccine Segment by Application

Pancreatic Cancer

Gastric Cancer

Breast Cancer

Prostate Cancer

Lung Cancer

Others

Peptide Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Peptide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Solution Phase Synthesis (SPS) Table 2. Major Company of Solid Phase Peptide Synthesis (SPPS) Table 3. Global Peptide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Peptide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Peptide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Peptide Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Peptide Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Peptide Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Peptide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Peptide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Peptide Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Peptide Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Peptide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Peptide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Peptide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Peptide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Peptide Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Peptide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Peptide Vaccine Industry Trends Table 25. Peptide Vaccine Industry Drivers Table 26. Peptide Vaccine Industry Opportunities and Challenges Table 27. Peptide Vaccine Industry Restraints Table 28. Global Peptide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Peptide Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Peptide Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Peptide Vaccine Sales Share by Company (2021-2026) Table 32. Global Peptide Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Peptide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Peptide Vaccine Major Company Production Sites and Headquarters Table 35. Global Peptide Vaccine Company, Product Type & Application Table 36. Global Peptide Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Peptide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Peptide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Peptide Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Peptide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Peptide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Peptide Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Peptide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Peptide Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Peptide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Peptide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Peptide Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Peptide Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Peptide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Peptide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Peptide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Peptide Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Peptide Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Peptide Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Peptide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Peptide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Peptide Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Peptide Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Peptide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Peptide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Peptide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Peptide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Peptide Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Peptide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Anergis Company Information Table 72. Anergis Business Overview Table 73. Anergis Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Anergis Peptide Vaccine Product Portfolio Table 75. Anergis Recent Development Table 76. Antigen Express Company Information Table 77. Antigen Express Business Overview Table 78. Antigen Express Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Antigen Express Peptide Vaccine Product Portfolio Table 80. Antigen Express Recent Development Table 81. Apitope Technology Company Information Table 82. Apitope Technology Business Overview Table 83. Apitope Technology Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Apitope Technology Peptide Vaccine Product Portfolio Table 85. Apitope Technology Recent Development Table 86. Artificial Cell Technologies Company Information Table 87. Artificial Cell Technologies Business Overview Table 88. Artificial Cell Technologies Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Artificial Cell Technologies Peptide Vaccine Product Portfolio Table 90. Artificial Cell Technologies Recent Development Table 91. Benovus Bio Company Information Table 92. Benovus Bio Business Overview Table 93. Benovus Bio Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Benovus Bio Peptide Vaccine Product Portfolio Table 95. Benovus Bio Recent Development Table 96. Celgene Corporation Company Information Table 97. Celgene Corporation Business Overview Table 98. Celgene Corporation Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Celgene Corporation Peptide Vaccine Product Portfolio Table 100. Celgene Corporation Recent Development Table 101. Immatics biotechnologies Company Information Table 102. Immatics biotechnologies Business Overview Table 103. Immatics biotechnologies Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Immatics biotechnologies Peptide Vaccine Product Portfolio Table 105. Immatics biotechnologies Recent Development Table 106. ImmunoCellular Therapeutics Company Information Table 107. ImmunoCellular Therapeutics Business Overview Table 108. ImmunoCellular Therapeutics Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. ImmunoCellular Therapeutics Peptide Vaccine Product Portfolio Table 110. ImmunoCellular Therapeutics Recent Development Table 111. ISA Pharmaceuticals Company Information Table 112. ISA Pharmaceuticals Business Overview Table 113. ISA Pharmaceuticals Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. ISA Pharmaceuticals Peptide Vaccine Product Portfolio Table 115. ISA Pharmaceuticals Recent Development Table 116. Lytix Biopharma Company Information Table 117. Lytix Biopharma Business Overview Table 118. Lytix Biopharma Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Lytix Biopharma Peptide Vaccine Product Portfolio Table 120. Lytix Biopharma Recent Development Table 121. OncoTherapy Science Company Information Table 122. OncoTherapy Science Business Overview Table 123. OncoTherapy Science Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. OncoTherapy Science Peptide Vaccine Product Portfolio Table 125. OncoTherapy Science Recent Development Table 126. Peptech Company Information Table 127. Peptech Business Overview Table 128. Peptech Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Peptech Peptide Vaccine Product Portfolio Table 130. Peptech Recent Development Table 131. Pharmasyntez Company Information Table 132. Pharmasyntez Business Overview Table 133. Pharmasyntez Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Pharmasyntez Peptide Vaccine Product Portfolio Table 135. Pharmasyntez Recent Development Table 136. Spotlight Innovation Company Information Table 137. Spotlight Innovation Business Overview Table 138. Spotlight Innovation Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Spotlight Innovation Peptide Vaccine Product Portfolio Table 140. Spotlight Innovation Recent Development Table 141. Sumitomo Dainippon Pharma Company Information Table 142. Sumitomo Dainippon Pharma Business Overview Table 143. Sumitomo Dainippon Pharma Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Sumitomo Dainippon Pharma Peptide Vaccine Product Portfolio Table 145. Sumitomo Dainippon Pharma Recent Development Table 146. TapImmune Company Information Table 147. TapImmune Business Overview Table 148. TapImmune Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. TapImmune Peptide Vaccine Product Portfolio Table 150. TapImmune Recent Development Table 151. Targovax Company Information Table 152. Targovax Business Overview Table 153. Targovax Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Targovax Peptide Vaccine Product Portfolio Table 155. Targovax Recent Development Table 156. Merck Company Information Table 157. Merck Business Overview Table 158. Merck Peptide Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Merck Peptide Vaccine Product Portfolio Table 160. Merck Recent Development Table 161. North America Peptide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. North America Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 163. North America Peptide Vaccine Sales Market Share by Country (2021-2026) Table 164. North America Peptide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 165. North America Peptide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. North America Peptide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. North America Peptide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. North America Peptide Vaccine Market Share by Country (2021-2026) Table 169. North America Peptide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. North America Peptide Vaccine Market Share Forecast by Country (2027-2032) Table 171. Europe Peptide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Europe Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 173. Europe Peptide Vaccine Sales Market Share by Country (2021-2026) Table 174. Europe Peptide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Europe Peptide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Europe Peptide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Europe Peptide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Europe Peptide Vaccine Market Share by Country (2021-2026) Table 179. Europe Peptide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Europe Peptide Vaccine Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Peptide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 183. Asia-Pacific Peptide Vaccine Sales Market Share by Country (2021-2026) Table 184. Asia-Pacific Peptide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 185. Asia-Pacific Peptide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Peptide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Peptide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 188. Asia-Pacific Peptide Vaccine Market Share by Country (2021-2026) Table 189. Asia-Pacific Peptide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Asia-Pacific Peptide Vaccine Market Share Forecast by Country (2027-2032) Table 191. Latin America Peptide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Latin America Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 193. Latin America Peptide Vaccine Sales Market Share by Country (2021-2026) Table 194. Latin America Peptide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 195. Latin America Peptide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 196. Latin America Peptide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Latin America Peptide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 198. Latin America Peptide Vaccine Market Share by Country (2021-2026) Table 199. Latin America Peptide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Latin America Peptide Vaccine Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Peptide Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Peptide Vaccine Sales by Country (2021-2026) & (K Units) Table 203. Middle East and Africa Peptide Vaccine Sales Market Share by Country (2021-2026) Table 204. Middle East and Africa Peptide Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 205. Middle East and Africa Peptide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Peptide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Peptide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 208. Middle East and Africa Peptide Vaccine Market Share by Country (2021-2026) Table 209. Middle East and Africa Peptide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Middle East and Africa Peptide Vaccine Market Share Forecast by Country (2027-2032) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Peptide Vaccine Distributors List Table 214. Peptide Vaccine Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Peptide Vaccine Image Figure 2. Global Peptide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Peptide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Peptide Vaccine Sales (2021-2032) & (K Units) Figure 5. Solution Phase Synthesis (SPS) Image Figure 6. Global Solution Phase Synthesis (SPS) Sales YoY Growth (2021-2032) & (K Units) Figure 7. Solid Phase Peptide Synthesis (SPPS) Image Figure 8. Global Solid Phase Peptide Synthesis (SPPS) Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Peptide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Peptide Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Peptide Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Peptide Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Peptide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Peptide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Peptide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Peptide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Peptide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Peptide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Peptide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Peptide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Peptide Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pancreatic Cancer Image Figure 24. Global Pancreatic Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 25. Gastric Cancer Image Figure 26. Global Gastric Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Breast Cancer Image Figure 28. Global Breast Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Prostate Cancer Image Figure 30. Global Prostate Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Lung Cancer Image Figure 32. Global Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Peptide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Peptide Vaccine Market Share by Application 2025 VS 2032 Figure 37. North America Peptide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. North America Peptide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Europe Peptide Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Europe Peptide Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Peptide Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Peptide Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Latin America Peptide Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Peptide Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Peptide Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Peptide Vaccine Sales Market Share in Value by Application in 2025 Figure 47. North America Peptide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Peptide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Peptide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Peptide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Peptide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Peptide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Peptide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Peptide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Peptide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Peptide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Peptide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Peptide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Peptide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Peptide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Peptide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Peptide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Peptide Vaccine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Peptide Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Solution Phase Synthesis (SPS)
  • Solid Phase Peptide Synthesis (SPPS)
Applications
  • Pancreatic Cancer
  • Gastric Cancer
  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Others
Companies covered
  • Anergis
  • Antigen Express
  • Apitope Technology
  • Artificial Cell Technologies
  • Benovus Bio
  • Celgene Corporation
  • Immatics biotechnologies
  • ImmunoCellular Therapeutics
  • ISA Pharmaceuticals
  • Lytix Biopharma
  • OncoTherapy Science
  • Peptech
  • Pharmasyntez
  • Spotlight Innovation
  • Sumitomo Dainippon Pharma
  • TapImmune
  • Targovax
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Peptide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Peptide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Peptide Vaccine Market by Type
  6. 1.3.1 Solution Phase Synthesis (SPS)
  7. 1.3.2 Solid Phase Peptide Synthesis (SPPS)
  8. 1.4 Global Peptide Vaccine Market Size by Type
  9. 1.4.1 Global Peptide Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Peptide Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Peptide Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Peptide Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Peptide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Peptide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Peptide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Peptide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Peptide Vaccine Industry Trends
  2. 2.2 Peptide Vaccine Industry Drivers
  3. 2.3 Peptide Vaccine Industry Opportunities and Challenges
  4. 2.4 Peptide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Peptide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Peptide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Peptide Vaccine Price (2021-2026)
  4. 3.4 Global Peptide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Peptide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Peptide Vaccine Company, Product Type & Application
  7. 3.7 Global Peptide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Peptide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Peptide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Peptide Vaccine Tier 1, Tier 2, and Tier 3
4 Peptide Vaccine Regional Status and Outlook
  1. 4.1 Global Peptide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Peptide Vaccine Historic Market Size by Region
  3. 4.2.1 Global Peptide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Peptide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Peptide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Peptide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Peptide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Peptide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Peptide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Peptide Vaccine by Application
  1. 5.1 Peptide Vaccine Market by Application
  2. 5.1.1 Pancreatic Cancer
  3. 5.1.2 Gastric Cancer
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Prostate Cancer
  6. 5.1.5 Lung Cancer
  7. 5.1.6 Others
  8. 5.2 Global Peptide Vaccine Market Size by Application
  9. 5.2.1 Global Peptide Vaccine Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Peptide Vaccine Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Peptide Vaccine Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Peptide Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Peptide Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Peptide Vaccine Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Peptide Vaccine Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Peptide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Anergis
  2. 6.1.1 Anergis Company Information
  3. 6.1.2 Anergis Business Overview
  4. 6.1.3 Anergis Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Anergis Peptide Vaccine Product Portfolio
  6. 6.1.5 Anergis Recent Developments
  7. 6.2 Antigen Express
  8. 6.2.1 Antigen Express Company Information
  9. 6.2.2 Antigen Express Business Overview
  10. 6.2.3 Antigen Express Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Antigen Express Peptide Vaccine Product Portfolio
  12. 6.2.5 Antigen Express Recent Developments
  13. 6.3 Apitope Technology
  14. 6.3.1 Apitope Technology Company Information
  15. 6.3.2 Apitope Technology Business Overview
  16. 6.3.3 Apitope Technology Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Apitope Technology Peptide Vaccine Product Portfolio
  18. 6.3.5 Apitope Technology Recent Developments
  19. 6.4 Artificial Cell Technologies
  20. 6.4.1 Artificial Cell Technologies Company Information
  21. 6.4.2 Artificial Cell Technologies Business Overview
  22. 6.4.3 Artificial Cell Technologies Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Artificial Cell Technologies Peptide Vaccine Product Portfolio
  24. 6.4.5 Artificial Cell Technologies Recent Developments
  25. 6.5 Benovus Bio
  26. 6.5.1 Benovus Bio Company Information
  27. 6.5.2 Benovus Bio Business Overview
  28. 6.5.3 Benovus Bio Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Benovus Bio Peptide Vaccine Product Portfolio
  30. 6.5.5 Benovus Bio Recent Developments
  31. 6.6 Celgene Corporation
  32. 6.6.1 Celgene Corporation Company Information
  33. 6.6.2 Celgene Corporation Business Overview
  34. 6.6.3 Celgene Corporation Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Celgene Corporation Peptide Vaccine Product Portfolio
  36. 6.6.5 Celgene Corporation Recent Developments
  37. 6.7 Immatics biotechnologies
  38. 6.7.1 Immatics biotechnologies Company Information
  39. 6.7.2 Immatics biotechnologies Business Overview
  40. 6.7.3 Immatics biotechnologies Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Immatics biotechnologies Peptide Vaccine Product Portfolio
  42. 6.7.5 Immatics biotechnologies Recent Developments
  43. 6.8 ImmunoCellular Therapeutics
  44. 6.8.1 ImmunoCellular Therapeutics Company Information
  45. 6.8.2 ImmunoCellular Therapeutics Business Overview
  46. 6.8.3 ImmunoCellular Therapeutics Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ImmunoCellular Therapeutics Peptide Vaccine Product Portfolio
  48. 6.8.5 ImmunoCellular Therapeutics Recent Developments
  49. 6.9 ISA Pharmaceuticals
  50. 6.9.1 ISA Pharmaceuticals Company Information
  51. 6.9.2 ISA Pharmaceuticals Business Overview
  52. 6.9.3 ISA Pharmaceuticals Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ISA Pharmaceuticals Peptide Vaccine Product Portfolio
  54. 6.9.5 ISA Pharmaceuticals Recent Developments
  55. 6.10 Lytix Biopharma
  56. 6.10.1 Lytix Biopharma Company Information
  57. 6.10.2 Lytix Biopharma Business Overview
  58. 6.10.3 Lytix Biopharma Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lytix Biopharma Peptide Vaccine Product Portfolio
  60. 6.10.5 Lytix Biopharma Recent Developments
  61. 6.11 OncoTherapy Science
  62. 6.11.1 OncoTherapy Science Company Information
  63. 6.11.2 OncoTherapy Science Business Overview
  64. 6.11.3 OncoTherapy Science Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 OncoTherapy Science Peptide Vaccine Product Portfolio
  66. 6.11.5 OncoTherapy Science Recent Developments
  67. 6.12 Peptech
  68. 6.12.1 Peptech Company Information
  69. 6.12.2 Peptech Business Overview
  70. 6.12.3 Peptech Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Peptech Peptide Vaccine Product Portfolio
  72. 6.12.5 Peptech Recent Developments
  73. 6.13 Pharmasyntez
  74. 6.13.1 Pharmasyntez Company Information
  75. 6.13.2 Pharmasyntez Business Overview
  76. 6.13.3 Pharmasyntez Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pharmasyntez Peptide Vaccine Product Portfolio
  78. 6.13.5 Pharmasyntez Recent Developments
  79. 6.14 Spotlight Innovation
  80. 6.14.1 Spotlight Innovation Company Information
  81. 6.14.2 Spotlight Innovation Business Overview
  82. 6.14.3 Spotlight Innovation Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Spotlight Innovation Peptide Vaccine Product Portfolio
  84. 6.14.5 Spotlight Innovation Recent Developments
  85. 6.15 Sumitomo Dainippon Pharma
  86. 6.15.1 Sumitomo Dainippon Pharma Company Information
  87. 6.15.2 Sumitomo Dainippon Pharma Business Overview
  88. 6.15.3 Sumitomo Dainippon Pharma Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sumitomo Dainippon Pharma Peptide Vaccine Product Portfolio
  90. 6.15.5 Sumitomo Dainippon Pharma Recent Developments
  91. 6.16 TapImmune
  92. 6.16.1 TapImmune Company Information
  93. 6.16.2 TapImmune Business Overview
  94. 6.16.3 TapImmune Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 TapImmune Peptide Vaccine Product Portfolio
  96. 6.16.5 TapImmune Recent Developments
  97. 6.17 Targovax
  98. 6.17.1 Targovax Company Information
  99. 6.17.2 Targovax Business Overview
  100. 6.17.3 Targovax Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Targovax Peptide Vaccine Product Portfolio
  102. 6.17.5 Targovax Recent Developments
  103. 6.18 Merck
  104. 6.18.1 Merck Company Information
  105. 6.18.2 Merck Business Overview
  106. 6.18.3 Merck Peptide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Merck Peptide Vaccine Product Portfolio
  108. 6.18.5 Merck Recent Developments
7 North America by Country
  1. 7.1 North America Peptide Vaccine Sales by Country
  2. 7.1.1 North America Peptide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Peptide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Peptide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Peptide Vaccine Market Size by Country
  6. 7.2.1 North America Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Peptide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Peptide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Peptide Vaccine Sales by Country
  2. 8.1.1 Europe Peptide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Peptide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Peptide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Peptide Vaccine Market Size by Country
  6. 8.2.1 Europe Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Peptide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Peptide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Peptide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Peptide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Peptide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Peptide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Peptide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Peptide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Peptide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Peptide Vaccine Sales by Country
  2. 10.1.1 South America Peptide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Peptide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Peptide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Peptide Vaccine Market Size by Country
  6. 10.2.1 South America Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Peptide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Peptide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Peptide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Peptide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Peptide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Peptide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Peptide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Peptide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Peptide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Peptide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Peptide Vaccine Value Chain Analysis
  2. 12.1.1 Peptide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Peptide Vaccine Production Mode & Process
  7. 12.2 Peptide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Peptide Vaccine Distributors
  10. 12.2.3 Peptide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst